Niklas Klümper (Niklas Kluemper)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Metastatic Renal Cell Carcinoma

Radical Prostatectomy

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sana Hosni, Viola Kilian, Niklas Klümper, Daniela Gabbia, Katharina Sieckmann, Dillon Corvino, Anja Winkler, Miriam Saponaro, Karin Woersdoerfer, Doris Schmidt, Oliver Hahn, Ilaria Zanotto, Marina Bertlich, Marieta Ioana Toma, Tobias Bald, Markus Eckstein, Michael Hudecek, Matthias Geyer, Manuel Ritter, Dagmar Wachten, Sara De Martin, Abdullah Alajati
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma. Cancer research 84 (5) (2024)
Thomas Büttner, Dimo Dietrich, Romina Zarbl, Niklas Klümper, Joerg Ellinger, Philipp Krausewitz, Manuel Ritter
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers 16 (3) (2024)
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Thomas Büttner, Dimo Dietrich, Romina Zarbl, Niklas Klümper, Joerg Ellinger, Philipp Krausewitz, Manuel Ritter
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers 16 (3) (2024)
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Sana Hosni, Viola Kilian, Niklas Klümper, Daniela Gabbia, Katharina Sieckmann, Dillon Corvino, Anja Winkler, Miriam Saponaro, Karin Woersdoerfer, Doris Schmidt, Oliver Hahn, Ilaria Zanotto, Marina Bertlich, Marieta Ioana Toma, Tobias Bald, Markus Eckstein, Michael Hudecek, Matthias Geyer, Manuel Ritter, Dagmar Wachten, Sara De Martin, Abdullah Alajati
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma. Cancer research 84 (5) (2024)
Sana Hosni, Viola Kilian, Niklas Klümper, Daniela Gabbia, Katharina Sieckmann, Dillon Corvino, Anja Winkler, Miriam Saponaro, Karin Woersdoerfer, Doris Schmidt, Oliver Hahn, Ilaria Zanotto, Marina Bertlich, Marieta Ioana Toma, Tobias Bald, Markus Eckstein, Michael Hudecek, Matthias Geyer, Manuel Ritter, Dagmar Wachten, Sara De Martin, Abdullah Alajati
Adipocyte precursor-derived NRG1 promotes resistance to FGFR inhibition in urothelial carcinoma. Cancer research (2024)
Benedikt Hoeh, Cristina Cano Garcia, Severine Banek, Niklas Klümper, Alexander Cox, Joerg Ellinger, Philipp Schmucker, Oliver Hahn, Angelika Mattigk, Friedemann Zengerling, Philippe Becker, Kati Erdmann, Bjoern Thorben Buerk, Luka Flegar, Johannes Huber, Charis Kalogirou, Philip Zeuschner
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitions. Clinical & translational immunology 12 (10) (2023)
Marthe von Danwitz, Niklas Klümper, Marit Bernhardt, Alexander Cox, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger, Johannes Stein
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. Cancers 15 (6) (2023)
Marthe von Danwitz, Niklas Klümper, Marit Bernhardt, Alexander Cox, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger, Johannes Stein
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. Cancers 15 (6) (2023)
Niklas Klümper, Joerg Ellinger
Insights into Urologic Cancer. Cancers 15 (12) (2023)
Niklas Klümper, Joerg Ellinger
Insights into Urologic Cancer. Cancers 15 (12) (2023)
Niklas Klümper, Damian J Ralser, Romina Zarbl, Katrin Schlack, Andres Jan Schrader, Marc Rehlinghaus, Michèle J Hoffmann, Günter Niegisch, Annemarie Uhlig, Lutz Trojan, Julie Steinestel, Konrad Steinestel, Ralph M Wirtz, Danijel Sikic, Markus Eckstein, Glen Kristiansen, Marieta Toma, Michael Hölzel, Manuel Ritter, Sebastian Strieth, Jörg Ellinger, Dimo Dietrich
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. Journal for immunotherapy of cancer 9 (8) (2022)
Philipp Krausewitz, Niklas Klümper, Ayk-Peter Richter, Thomas Büttner, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis. Cancers 14 (18) (2022)
Niklas Klümper, Damian J Ralser, Joerg Ellinger, Florian Roghmann, Julia Albrecht, Eduard Below, Abdullah Alajati, Danijel Sikic, Johannes Breyer, Christian Bolenz, Friedemann Zengerling, Philipp Erben, Kristina Schwamborn, Ralph M Wirtz, Thomas Horn, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Thomas Büttner, Oliver Hahn, Viktor Gruenwald, Christopher Darr, Eva Erne, Steffen Rausch, Jens Bedke, Katrin Schlack, Mahmoud Abbas, Stefanie Zschäbitz, Constantin Schwab, Alexander Mustea, Patrick Adam, Andreas Manseck, Bernd Wullich, Manuel Ritter, Arndt Hartmann, Juergen E Gschwend, Wilko Weichert, Franziska Erlmeier, Michael Hudecek, Markus Eckstein
Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with enfortumab vedotin resistance. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Larissa Gundert, Alexander Strick, Felix von Hagen, Doris Schmidt, Niklas Klümper, Yuri Tolkach, Marieta Ioana Toma, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
Systematic expression analysis of m 6 A RNA methyltransferases in clear cell renal cell carcinoma. BJUI compass 2 (6) (2021)
Niklas Klümper, Philipp Schmucker, Oliver Hahn, Benedikt Höh, Angelika Mattigk, Severine Banek, Joerg Ellinger, Julia Heinzelbecker, Danijel Sikic, Markus Eckstein, Arne Strauß, Friedemann Zengerling, Michael Hudecek, Philip Zeuschner, Charis Kalogirou
C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma. Clinical & translational immunology 10 (12) (2021)
Niklas Klümper, Marthe von Danwitz, Johannes Stein, Doris Schmidt, Anja Schmidt, Glen Kristiansen, Michael Muders, Michael Hölzel, Manuel Ritter, Abdullah Alajati, Joerg Ellinger
Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers. Cancers 12 (11) (2020)